PMID- 21979951 OWN - NLM STAT- MEDLINE DCOM- 20120221 LR - 20220330 IS - 1083-351X (Electronic) IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 286 IP - 49 DP - 2011 Dec 9 TI - Akt2 kinase suppresses glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-mediated apoptosis in ovarian cancer cells via phosphorylating GAPDH at threonine 237 and decreasing its nuclear translocation. PG - 42211-42220 LID - S0021-9258(20)87111-7 [pii] LID - 10.1074/jbc.M111.296905 [doi] AB - Protein kinase B (Akt) plays important roles in regulation of cell growth and survival, but while many aspects of its mechanism of action are known, there are potentially additional regulatory events that remain to be discovered. Here we detected a 36-kDa protein that was co-immunoprecipitated with protein kinase Bbeta (Akt2) in OVCAR-3 ovarian cancer cells. The protein was identified to be glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by MALDI-TOF/TOF MS, and the interaction of Akt2 and GAPDH was verified by reverse immunoprecipitation. Our further study showed that Akt2 may suppress GAPDH-mediated apoptosis in ovarian cancer cells. Overexpression of GAPDH increased ovarian cancer cell apoptosis induced by H(2)O(2), which was inhibited by Akt2 overexpression and restored by the PI3K/Akt inhibitor wortmannin or Akt2 siRNA. Akt2 phosphorylated Thr-237 of GAPDH and decreased its nuclear translocation, an essential step for GAPDH-mediated apoptosis. The interaction between Akt2 and GAPDH may be important in ovarian cancer as immunohistochemical analysis of 10 normal and 30 cancerous ovarian tissues revealed that decreased nuclear expression of GAPDH correlated with activation (phosphorylation) of Akt2. In conclusion, our study suggests that activated Akt2 may increase ovarian cancer cell survival via inhibition of GAPDH-induced apoptosis. This effect of Akt2 is partly mediated by its phosphorylation of GAPDH at Thr-237, which results in the inhibition of GAPDH nuclear translocation. FAU - Huang, Qiaojia AU - Huang Q AD - Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. Electronic address: huangqj100@126.com. FAU - Lan, Fenghua AU - Lan F AD - Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Zheng, Zhiyong AU - Zheng Z AD - Department of Pathology, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Xie, Feilai AU - Xie F AD - Department of Pathology, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Han, Junyong AU - Han J AD - Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Dong, Lihong AU - Dong L AD - Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Xie, Yanchuan AU - Xie Y AD - Department of Experimental Medicine, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. FAU - Zheng, Feng AU - Zheng F AD - Department of Nephrology, Fuzhou General Hospital (Dongfang Hospital), 156 North Xi-er Huan Road, Fuzhou City, Fujian Province 350025, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20111006 PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - EC 1.2.1.- (Glyceraldehyde-3-Phosphate Dehydrogenases) RN - EC 2.7.11.1 (Proto-Oncogene Proteins c-akt) SB - IM MH - Active Transport, Cell Nucleus MH - Amino Acid Sequence MH - Apoptosis MH - Cell Line, Tumor MH - Cell Survival MH - Cytoplasm/metabolism MH - Female MH - Glyceraldehyde-3-Phosphate Dehydrogenases/*metabolism MH - Humans MH - Models, Molecular MH - Molecular Sequence Data MH - Mutagenesis, Site-Directed MH - Ovarian Neoplasms/metabolism MH - Phosphorylation MH - Proto-Oncogene Proteins c-akt/*metabolism MH - RNA Interference PMC - PMC3234938 EDAT- 2011/10/08 06:00 MHDA- 2012/02/22 06:00 PMCR- 2012/12/09 CRDT- 2011/10/08 06:00 PHST- 2011/10/08 06:00 [entrez] PHST- 2011/10/08 06:00 [pubmed] PHST- 2012/02/22 06:00 [medline] PHST- 2012/12/09 00:00 [pmc-release] AID - S0021-9258(20)87111-7 [pii] AID - M111.296905 [pii] AID - 10.1074/jbc.M111.296905 [doi] PST - ppublish SO - J Biol Chem. 2011 Dec 9;286(49):42211-42220. doi: 10.1074/jbc.M111.296905. Epub 2011 Oct 6.